These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28988625)

  • 1. In vivo programming of endogenous antibodies via oral administration of adaptor ligands.
    Nagano M; Carrillo N; Otsubo N; Hakamata W; Ban H; Fuller RP; Bashiruddin NK; Barbas CF
    Bioorg Med Chem; 2017 Nov; 25(21):5952-5961. PubMed ID: 28988625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of biotinylated hapten-avidin complexes.
    Scott D; Nitecki DE; Kindler H; Goodman JW
    Mol Immunol; 1984 Nov; 21(11):1055-60. PubMed ID: 6440008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of model antigens composed of biotinylated haptens bound to avidin.
    Kane P; Holowka D; Baird B
    Immunol Invest; 1990 Feb; 19(1):1-25. PubMed ID: 2338359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
    Jalah R; Torres OB; Mayorov AV; Li F; Antoline JF; Jacobson AE; Rice KC; Deschamps JR; Beck Z; Alving CR; Matyas GR
    Bioconjug Chem; 2015 Jun; 26(6):1041-53. PubMed ID: 25970207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoreversible antigen-antibody reactions.
    Harada M; Sisido M; Hirose J; Nakanishi M
    FEBS Lett; 1991 Jul; 286(1-2):6-8. PubMed ID: 1864380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological mimicry of antigenic stimulation: analysis of the in vivo antibody responses induced by monoclonal anti-idiotypic antibodies.
    Huang JY; Ward RE; Kohler H
    Immunology; 1988 Jan; 63(1):1-8. PubMed ID: 3338815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method of stimulating an immune response with a hapten immobilized on a nitrocellulose membrane.
    Liu JJ; Wang CC; Hwang YL; Yue S; Chang TH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1995 Feb; 28(1):13-20. PubMed ID: 9774980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of passively administered isologous anti-idiotypes directed against anti-carrier (ovalbumin) antibodies on the anti-hapten IgE and IgG antibody responses in BALB/c mice.
    Blaser K; Nakagawa T; De Weck AL
    Immunology; 1983 Mar; 48(3):423-31. PubMed ID: 6600704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral tolerance to haptens: intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit hapten-specific T cell activation in vitro.
    Galliaerde V; Desvignes C; Peyron E; Kaiserlian D
    Eur J Immunol; 1995 May; 25(5):1385-90. PubMed ID: 7774642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell co-operation and hapten--carrier complexes.
    Snippe H; Kamp E
    Immunology; 1975 Oct; 29(4):675-85. PubMed ID: 52618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hapten presentation on antibody binding at lipid membrane interfaces.
    Jung H; Yang T; Lasagna MD; Shi J; Reinhart GD; Cremer PS
    Biophys J; 2008 Apr; 94(8):3094-103. PubMed ID: 18199665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hapten-directed spontaneous disulfide shuffling: a universal technology for site-directed covalent coupling of payloads to antibodies.
    Dengl S; Hoffmann E; Grote M; Wagner C; Mundigl O; Georges G; Thorey I; Stubenrauch KG; Bujotzek A; Josel HP; Dziadek S; Benz J; Brinkmann U
    FASEB J; 2015 May; 29(5):1763-79. PubMed ID: 25670234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hapten-coupled monoclonal anti-I-A antibodies provide a first signal for the induction of suppression.
    Bromberg JS; Nepom JT; Benacerraf B; Greene MI
    J Immunol; 1982 Feb; 128(2):834-7. PubMed ID: 6459387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence.
    Laudenbach M; Tucker AM; Runyon SP; Carroll FI; Pravetoni M
    Vaccine; 2015 Nov; 33(46):6332-9. PubMed ID: 26409811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-hapten interactions in vivo in mice and sheep.
    Jonas WE; Davey J; Pulford HD
    Res Vet Sci; 1975 Nov; 19(3):235-40. PubMed ID: 56024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the anti-hapten IgE antibody response with hapten-modified spleen cells.
    Weber EA; Blaser K
    Eur J Immunol; 1986 Dec; 16(12):1527-31. PubMed ID: 2949982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the cell-mediated cytotoxic responses of isogeneic ginbuna crucian carp induced by oral immunisation with hapten-modified cellular antigens.
    Sato A; Okamoto N
    Fish Shellfish Immunol; 2008 Jun; 24(6):684-92. PubMed ID: 18407518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An organophosphorus hapten used in the preparation of monoclonal antibody and as an active immunization vaccine in the detoxication of soman poisoning.
    Jia P; Wang Y; Yu M; Wu J; Yang R; Zhao Y; Zhou L
    Toxicol Lett; 2009 May; 187(1):45-51. PubMed ID: 19429243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of anti-hapten antibody response in vitro by hapten-carrier conjugates.
    Bernstein A; Globerson A
    Eur J Immunol; 1977 Sep; 7(9):598-602. PubMed ID: 923631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hapten Design and Monoclonal Antibody to Fluoroacetamide, a Small and Highly Toxic Chemical.
    Yang L; Zhang X; Shen D; Yu X; Li Y; Wen K; Shen J; Wang Z
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32630260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.